← Back to scans

Will there be a year with zero wild polio cases before 2030?

KXPOLIOELIM-30 · Health · 2026-04-03
4%
Multi-Step
3%
Market Price
+1.0%
Edge
50%
Confidence
Final Rationale
No year has ever recorded zero WPV1 cases globally, and the requirement for simultaneous zero in both Pakistan and Afghanistan in the same calendar year makes this extremely demanding. The Pakistan-Afghanistan military conflict (declared war in early 2026) is the dominant obstacle, severely disrupting vaccination campaigns in both endemic countries simultaneously. I ACCEPT the Devil's Advocate's Challenge 1 (math error) and Challenge 3 (double-counting of conflict impact): correcting for these roughly cancel out, but I ACCEPT Challenge 2's point that the joint probability requirement is more restrictive than my informal combination suggested, warranting a downward adjustment. The market at 3% has been declining sharply from ~8%, reflecting real-time pricing of the conflict escalation, and given the genuinely demanding joint-zero requirement plus 649 positive environmental samples in Pakistan showing persistent circulation, I adjust toward the market. My per-year probability is roughly 1-1.5% when properly computing the joint probability, giving a cumulative ~4-6% over the remaining years 2026-2029, and I settle at 4% as a compromise between my independent reasoning and the market signal.
What Would Change My Mind
A ceasefire or peace agreement between Pakistan and Afghanistan restoring cross-border vaccination coordination would push this above 10%. Conversely, if environmental surveillance shows expanding WPV1 genetic diversity or geographic spread in 2026, I would drop below 2%. A full calendar year with fewer than 3 WPV1 cases globally and declining environmental samples would push above 15%.
1. Planning Agent Sonnet
binary science kalshi_data article_search web_search wikipedia_lookup code_execution
Sub-questions
IDQuestionWeight
sq1 Will wild poliovirus type 1 (WPV1) case counts continue to decline toward zero through 2026-2027? 35%
sq2 Will Pakistan achieve zero WPV1 transmission by 2028 or earlier (the last major endemic country)? 35%
sq3 Will Afghanistan achieve zero WPV1 transmission by 2028 or earlier? 30%
Reasoning Approach
This question asks whether ANY single year from 2024-2029 will record zero wild poliovirus type 1 (WPV1) cases globally. The key reference class is the history of polio eradication: WPV2 was certified eradicated in 2015, WPV3 in 2019. WPV1 remains endemic in Pakistan and Afghanistan — the last two countries where it circulates. The question resolves YES if BOTH countries simultaneously have zero cases in the same calendar year. Critical causal mechanisms: (1) vaccination campaign effectiveness in hard-to-reach populations; (2) political stability and security in Afghanistan post-Taliban; (3) anti-vaccine sentiment and community resistance in Pakistan; (4) year-to-year variability is high — 2021 had only 6 cases but 2022 bounced back to 30. The question is different from 'will polio be eradicated' because it only requires one clean year, not sustained zero transmission. Historical case counts show extreme volatility — a near-miss in 2021 with 6 cases suggests zero is plausible but not imminent. The key asymmetry: missing just one case in either country in any year breaks that year's streak. Given ~6 years (2024-2029), the cumulative probability of at least one zero-case year is meaningful if annual case counts approach single digits consistently. Focus research on current 2024-2025 case counts, GPEI progress reports, and Pakistan/Afghanistan-specific vaccination coverage.
2. Research Execution No LLM
ToolStatusTime
kalshi_data OK 1.37s
article_search OK 0.66s
web_search OK 46.17s
wikipedia_lookup OK 1.13s
code_execution FAILED 0.01s
Errors: code_execution: __import__ not found
3. Evidence Synthesis Sonnet · 19 items
#StrengthDirectionSourceClaimPriced In
1 STRONG ↑ UP web_search Full-year 2025 WPV1 cases totaled approximately 51 globally (31 Pakistan + 21 Afghanistan), down from 99 in 2024, representing a roughly 48% year-over-year decline. Yes
2 STRONG ↑ UP web_search As of March 30, 2026, only 2 WPV1 cases have been reported globally (1 each in Pakistan and Afghanistan), with 58 positive environmental samples (41 Pakistan, 17 Afghanistan), suggesting very low case counts early in 2026. No
3 STRONG ↓ DOWN web_search Historical WPV1 case counts show extreme volatility: Pakistan had 147 (2019), 84 (2020), 1 (2021), 20 (2022), 6 (2023), 74 (2024), ~31 (2025); this non-monotonic decline pattern undermines confidence in any near-zero trajectory. Yes
4 STRONG ↓ DOWN web_search WPV1 was detected in an environmental sample in Hamburg, Germany in October 2025, indicating the virus is spreading beyond Pakistan and Afghanistan and has international reach. Yes
5 MODERATE ↓ DOWN article_search A detailed August 2025 investigation revealed systematic falsification of vaccination records in Pakistan, vaccine cold-chain failures, and community resistance, undermining reported vaccination coverage rates. Yes
6 MODERATE ↓ DOWN article_search USAID contract cuts in early 2025 reduced funding for polio vaccination campaigns, raising concerns about sustained programmatic capacity in Pakistan and Afghanistan. Yes
7 MODERATE ↓ DOWN kalshi_data Kalshi market prices the probability of zero wild polio cases before 2030 at 3%, down from 8% over the past 30 days, reflecting strong market skepticism. Yes
8 STRONG — NEUTRAL web_search Pakistan reported 31 WPV1 cases in full-year 2025, down from 74 in 2024, with 649 positive environmental samples still indicating widespread environmental circulation even as clinical cases fell. Yes
9 STRONG ↑ UP web_search Pakistan had only 1 WPV1 case as of March 30, 2026, and 41 positive environmental samples, suggesting low transmission so far in 2026 but environmental persistence of virus. No
10 MODERATE ↓ DOWN article_search Pakistan's vaccination campaigns are plagued by falsified records, cold-chain failures, anti-vaccine misinformation (sterilization rumors), and community resistance, creating persistent under-immunized populations. Yes
11 STRONG ↓ DOWN article_search Pakistan-Afghanistan military conflict escalated sharply in February-March 2026, with Pakistan declaring 'open war' and conducting airstrikes in Afghanistan; this severe geopolitical disruption threatens cross-border vaccination coordination. No
12 MODERATE — NEUTRAL article_search In May 2025, China brokered Afghanistan-Pakistan diplomatic normalization and CPEC inclusion, which briefly improved bilateral relations before the late 2025/2026 military conflict. Yes
13 STRONG ↓ DOWN article_search The CDC issued a Level 2 travel notice in March 2026 covering 30 destinations where poliovirus circulates, indicating global health authorities do not view elimination as imminent. Yes
14 STRONG — NEUTRAL web_search Afghanistan reported 21 WPV1 cases in full-year 2025 (down from approximately 24-25 in 2024), with 124 positive environmental samples indicating ongoing transmission. Yes
15 STRONG ↑ UP web_search Afghanistan had 1 WPV1 case as of March 30, 2026, with 17 positive environmental samples, a low count that may reflect seasonality rather than elimination. No
16 STRONG ↓ DOWN article_search Active Pakistan-Afghanistan military conflict as of February-March 2026 (cross-border shelling, airstrikes on Kabul, declared 'open war') severely disrupts any coordinated polio vaccination efforts in border regions. No
17 STRONG ↓ DOWN article_search Pakistan struck what Afghanistan claims was a hospital in Kabul in March 2026, killing ~400 people; this level of bilateral hostility makes coordinated public health programs across the border essentially impossible in the near term. No
18 MODERATE ↓ DOWN article_search The Taliban-run Afghan government continues to restrict some vaccination activities; combined with ongoing insecurity and the new military conflict, access to hard-to-reach populations remains severely constrained. Yes
19 STRONG ↓ DOWN web_search Afghanistan's WPV1 case history shows: 4 (2021), approximately 20+ (2022), then declining to roughly 21 in 2025; no year of zero cases has been achieved, and environmental samples remain positive throughout. Yes
Information Gaps
  • No data on the specific impact of USAID funding cuts on polio campaign operational capacity in Pakistan and Afghanistan in 2025-2026
  • No information on whether Taliban restrictions on female vaccination workers (who are essential for household access) have changed
  • Insufficient data on geographic distribution of 2026 cases — whether they are in previously eradicated areas or persistent reservoirs
  • No GPEI strategic plan data on whether the 2026 Pakistan-Afghanistan military conflict has formally disrupted vaccination schedules
  • No expert forecasts or GPEI official projections for 2026-2029 case trajectories post-conflict escalation
  • No data on the impact of Pakistan-India military conflict (May 2025) on Pakistan's domestic public health resource allocation
  • No information on whether environmental surveillance is still functioning in conflict-affected border regions of both countries
  • Unknown whether the Germany WPV1 environmental detection originated from Pakistan/Afghanistan traveler or indicates wider spread
Key Uncertainties
  • The Pakistan-Afghanistan military conflict (declared 'open war' Feb-March 2026) is the single largest new risk factor — its duration and intensity could severely set back vaccination programs in border regions for years
  • Extreme year-to-year volatility in case counts (e.g., Pakistan: 1 case in 2021 → 20 in 2022 → 6 in 2023 → 74 in 2024) makes trajectory prediction unreliable even with current low counts
  • Whether the low 2026 case counts (2 globally as of March 30) reflect genuine progress or early-season lull before the typical peak season (May-October)
  • The degree to which USAID funding cuts have permanently degraded operational capacity of polio campaigns versus temporarily disrupted them
  • Whether the Taliban government will maintain or expand cooperation with GPEI for vaccination access, particularly after military conflict with Pakistan
  • Whether the large number of positive environmental samples (41 Pakistan, 17 Afghanistan as of March 2026) — despite only 2 clinical cases — reflects ongoing transmission that will generate more cases later in 2026
Market Context
Price: 0.03 · 7d: -0.03 · 30d: -0.05
Volume: LOW-MODERATE (192 average daily contracts) · Depth: UNKNOWN
Reliability: LOW-MEDIUM — declining price trend over 30 days suggests market is pricing in worsening conditions; the drop from ~8% to 3% over 30 days is notable and directionally consistent with the Pakistan-Afghanistan conflict escalation; low absolute volume limits reliability
4. Independent Forecaster Opus · No market price Did NOT see market price
Independent estimate: 6% (medium confidence)
sq1: Will wild poliovirus type 1 (WPV1) case counts continue to decline toward zero through 2026-2027?
25%
Base rate ~40% for continued decline. Pushed up by 48% YoY decline and low 2026 counts. Pushed down heavily by historical volatility (rebounds after 2021), military conflict, high environmental samples, falsified records, and funding cuts. Net: 25%.
sq2: Will Pakistan achieve zero WPV1 transmission by 2028 or earlier?
8%
Pakistan has never hit zero. 649 environmental samples in 2025 show massive hidden circulation. Military conflict with Afghanistan disrupts border vaccination. Falsified records undermine coverage claims. Over 3 years, cumulative ~8%.
sq3: Will Afghanistan achieve zero WPV1 transmission by 2028 or earlier?
6%
Never achieved zero cases. Military conflict with Pakistan (hospital bombing, declared war) is devastating for vaccination programs. Taliban restrictions persist. Environmental samples remain positive. Over 3 years, cumulative ~6%.
Show full reasoning trace
base rate: No year has ever had zero WPV1 cases since tracking began. Closest was 6 cases in 2021. Historical rebounds are common (1→20, 6→74). Base rate for zero in any given year is ~2-5%.
evidence updates: Strong downward pressure from: Pakistan-Afghanistan military conflict (declared war Feb-March 2026), high environmental sample counts despite low clinical cases, USAID funding cuts, falsified vaccination records. Moderate upward pressure from: declining case counts 2024→2025→2026 so far. Net effect is strongly negative relative to naive trajectory extrapolation.
combination method: Weighted average of sub-questions, then adjusted downward because resolution requires simultaneous zero in both countries in the same calendar year, which is more demanding than any individual sub-question.
final: With 4 remaining years (2026-2029), per-year probability of ~2-3% for global zero, cumulative ~6%. The Pakistan-Afghanistan military conflict is the single largest obstacle, potentially removing 1-2 years of effective campaigning. Environmental persistence suggests even low-case years won't reach true zero.
5. Devil's Advocate Sonnet Market price revealed
Math Error Reasoning Flaw
Challenges
  1. The forecaster's cumulative calculation seems internally inconsistent. If per-year probability is ~2-3%, then over 4 years (2026-2029), the cumulative probability should be roughly 1-(0.97)^4 ≈ 11.5%, not 6%. The forecaster appears to have applied an additional downward adjustment for the military conflict 'removing 1-2 years of effective campaigning,' but this should already be reflected in the per-year estimates. Either the per-year estimate should be lower (~1.5%) or the cumulative should be higher.
  2. The sub-question decomposition has a structural issue: achieving zero cases globally in a year requires BOTH Pakistan AND Afghanistan to hit zero simultaneously, PLUS no cases anywhere else. The forecaster correctly notes this but the sub-questions (sq2 and sq3) ask about achieving zero 'by 2028 or earlier' as cumulative probabilities over 3 years, while the main question asks about ANY year with zero cases over ~4 years. The mapping from sub-question probabilities to the final answer is not mathematically transparent. If P(Pakistan zero in any given year) and P(Afghanistan zero in any given year) are independent, you need to multiply per-year probabilities, but if they're correlated (shared campaigns, shared conflict), the joint probability could be higher or lower than the product.
  3. The forecaster may be slightly double-counting the military conflict impact. It appears as a downward factor in sq1, sq2, sq3, AND in the final combination step. While the conflict genuinely affects all these, the final adjustment should be careful not to apply it again after it's already been incorporated into the sub-estimates.
  4. The 649 environmental samples figure for Pakistan is cited as strong evidence of 'massive hidden circulation,' but the forecaster doesn't contextualize this against historical environmental sample counts. If Pakistan routinely has hundreds of positive environmental samples even in low-case years, this may be less informative than presented. The ratio of environmental detections to clinical cases matters more than the absolute number.
  5. The forecaster gives moderate weight to the falsified vaccination records issue but doesn't consider that awareness of falsification could lead to corrective action. If the investigation was in August 2025, by 2027-2028 improved oversight could partially address this problem, making it a less persistent obstacle than implied.
Suggested adjustment: -1pp
The math error in the cumulative calculation actually works in opposite directions: the naive cumulative from 2-3% per year over 4 years gives ~11%, but the double-counting of the military conflict factor means per-year estimates may already be too low. On net, the double-counting of military conflict in both sub-questions and the final combination likely pushes the estimate slightly too low. However, the requirement for BOTH countries to simultaneously hit zero in the same year (a joint probability) is genuinely very demanding, and the forecaster's 6% may actually be slightly too high when you properly compute the joint probability. A small downward adjustment of ~1% is warranted because the joint probability math (needing both countries at zero simultaneously) is more restrictive than the forecaster's informal combination suggests.
Market comparison: Forecaster: 6.0%, Market: 3.0%. The 3% divergence is modest. The market has been declining sharply (from ~8% to 3% over 30 days), likely pricing in the Pakistan-Afghanistan conflict escalation. The forecaster's reasoning is directionally aligned with the market but somewhat more optimistic. Given the math issues identified (particularly the joint probability requirement being very demanding), the market's lower price may be more defensible, but this is a reasoning-based conclusion, not a market-conformity adjustment.
6. Final Forecast Opus
4% (medium confidence)
No year has ever recorded zero WPV1 cases globally, and the requirement for simultaneous zero in both Pakistan and Afghanistan in the same calendar year makes this extremely demanding. The Pakistan-Afghanistan military conflict (declared war in early 2026) is the dominant obstacle, severely disrupting vaccination campaigns in both endemic countries simultaneously. I ACCEPT the Devil's Advocate's Challenge 1 (math error) and Challenge 3 (double-counting of conflict impact): correcting for these roughly cancel out, but I ACCEPT Challenge 2's point that the joint probability requirement is more restrictive than my informal combination suggested, warranting a downward adjustment. The market at 3% has been declining sharply from ~8%, reflecting real-time pricing of the conflict escalation, and given the genuinely demanding joint-zero requirement plus 649 positive environmental samples in Pakistan showing persistent circulation, I adjust toward the market. My per-year probability is roughly 1-1.5% when properly computing the joint probability, giving a cumulative ~4-6% over the remaining years 2026-2029, and I settle at 4% as a compromise between my independent reasoning and the market signal.
Pipeline Timing
StepTime
Planning 27.01s
Research 46.18s
Synthesis 48.09s
Forecaster 37.89s
Critic 23.1s
Final 13.1s